Cargando…

Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network

Detalles Bibliográficos
Autores principales:	Termini, Christina M., Moseley, Anna, Othus, Megan, Appelbaum, Frederick R., Chauncey, Thomas R., Erba, Harry P., Fang, Min, Lee, Stanley C., Naru, Jasmine, Pogosova-Agadjanyan, Era L., Radich, Jerald P., Willman, Cheryl L., Wu, Feinan, Meshinchi, Soheil, Stirewalt, Derek L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620555/ https://www.ncbi.nlm.nih.gov/pubmed/37021537 http://dx.doi.org/10.3324/haematol.2023.282733

Ejemplares similares

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2020)

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2023)

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis
por: Zarnegar-Lumley, Sara, et al.
Publicado: (2023)

The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2013)

Experiences with a researcher-centric ELN
por: Badiola, Katrina A., et al.
Publicado: (2015)

The New ELN Recommendations for Treating CML
por: Hehlmann, Rüdiger
Publicado: (2020)

Institutional ELN/LIMS deployment: Highly customizable ELN/LIMS platform as a cornerstone of digital transformation for life sciences research institutes
por: Argento, Nicolas
Publicado: (2020)

Gene Expression Patterns in Myelodyplasia Underline the Role of Apoptosis and Differentiation in Disease Initiation and Progression
por: Bar, Merav, et al.
Publicado: (2008)

What is VaxEln really like?: a user's view
por: Burkimsher, Paul C
Publicado: (1985)

Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML
por: Stirewalt, D L, et al.
Publicado: (2014)

ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2020)

ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
por: Buccisano, Francesco, et al.
Publicado: (2022)

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Bill, Marius, et al.
Publicado: (2023)

Subnuclear physics: the first 50 years, highlights from Erice to ELN
por: Zichichi, A, et al.
Publicado: (2000)

Subnuclear physics: the first fifty years, highlights from Erice to ELN
por: Zichichi, Antonino, et al.
Publicado: (1998)

openBIS ELN-LIMS: an open-source database for academic laboratories
por: Barillari, Caterina, et al.
Publicado: (2016)

Chemotion ELN: an Open Source electronic lab notebook for chemists in academia
por: Tremouilhac, Pierre, et al.
Publicado: (2017)

Emerging Role of Edible Exosomes-Like Nanoparticles (ELNs) as Hepatoprotective Agents
por: Subudhi, P. Debishree, et al.
Publicado: (2022)

ELN missense variant in patient with mid-aortic syndrome case report
por: Phan, Thao Nguyen, et al.
Publicado: (2022)

AI4Green: An Open-Source ELN for Green and Sustainable Chemistry
por: Boobier, Samuel, et al.
Publicado: (2023)

Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022
por: Bouligny, Ian M., et al.
Publicado: (2023)

Chemotion-ELN part 2: adaption of an embedded Ketcher editor to advanced research applications
por: Kotov, Serhii, et al.
Publicado: (2018)

Upregulation of key genes Eln and Tgfb3 were associated with the severity of cardiac hypertrophy
por: Zhang, Rui, et al.
Publicado: (2022)

Novel mutation in ELN gene causes cardiac abnormalities and inguinal hernia: case report
por: Zhang, Hua-yong, et al.
Publicado: (2023)

Novel ELN mutation in a Japanese family with a severe form of supravalvular aortic stenosis
por: Sugiyama, Kaori, et al.
Publicado: (2019)

A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies
por: Velandia-Piedrahita, Camilo Andres, et al.
Publicado: (2020)

Identification and characterization of a novel ELN mutation in congenital heart disease with pulmonary artery stenosis
por: Hou, Cuilan, et al.
Publicado: (2021)

Subnuclear physics: the first fifty years, highlights from Erice to ELN : Festschrift Galvani (Luigi) Bicentenary
por: Zichichi, Antonino, et al.
Publicado: (1999)

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2022)

Improved outcomes with “7+3” induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data
por: Othus, Megan, et al.
Publicado: (2022)

Relative survival following response to 7+3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes:An analysis of four SWOG studies
por: Othus, Megan, et al.
Publicado: (2018)

How I treat obesity and obesity related surgery in patients with chronic myeloid leukemia: An outcome of an ELN project
por: Yassin, Mohamed A., et al.
Publicado: (2021)

P434: MYELODYSPLASIA-RELATED MUTATIONS IN THE NEW ELN CLASSIFICATION: DOES CLONAL SIZE PLAY A ROLE?
por: Rausch, Christian, et al.
Publicado: (2023)

The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients
por: Wang, Xiaoning, et al.
Publicado: (2023)

P1280: COMPARING TRANSPLANT OUTCOMES OF AML PATIENTS FOR 2017 AND 2022 ELN RISK STRATIFICATION: A REAL-WORLD STUDY FROM A SINGLE CENTER IN CHINA
por: Zhang, Haixiao, et al.
Publicado: (2023)

The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
por: Chi, Huiying, et al.
Publicado: (2017)

SCD and MTHFD2 inhibitors for high‐risk acute myeloid leukaemia patients, as suggested by ELN2017‐pathway association
por: Kim, Han Sun, et al.
Publicado: (2023)

P508: THE PROGNOSTIC SIGNIFICANCE OF THE MEASURABLE RESIDUAL DISEASE STATUS WITHIN THE THREE AML ELN2022 RISK GROUPS
por: Bischof, Lara, et al.
Publicado: (2023)

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia
por: Farrar, Jason E., et al.
Publicado: (2023)

Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC
por: Huber, Sandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ssajjolpo9jl85kduk42bajioj